Cargando…

T-cell activation, senescence, and exhaustion in asymptomatic HIV/Leishmania infantum co-infection

BACKGROUND: Leishmania infantum is an opportunistic parasitic infection. An immunocompromised state increases the risk of converting asymptomatic infection to symptomatic visceral leishmaniasis (VL), which has a ~5% fatality rate even with treatment. HIV coinfection increases the risk of death from...

Descripción completa

Detalles Bibliográficos
Autores principales: de Oliveira Mendes-Aguiar, Carolina, do Monte Alves, Manoella, de Albuquerque Lopes Machado, Amanda, de Góis Monteiro, Glória Regina, Medeiros, Iara Marques, Queiroz, Jose Wilton, Lima, Iraci Duarte, Pearson, Richard D., Wilson, Mary E., Glesby, Marshall J., do Nascimento, Eliana Lúcia Tomaz, Jerônimo, Selma Maria Bezerra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029033/
https://www.ncbi.nlm.nih.gov/pubmed/36945413
http://dx.doi.org/10.1101/2023.03.06.23286828
Descripción
Sumario:BACKGROUND: Leishmania infantum is an opportunistic parasitic infection. An immunocompromised state increases the risk of converting asymptomatic infection to symptomatic visceral leishmaniasis (VL), which has a ~5% fatality rate even with treatment. HIV coinfection increases the risk of death from VL. METHODS: A cross-sectional study was performed between 2014 and 2016 to determine the prevalence of L. infantum infection in HIV positive subjects residing in the state of Rio Grande do Norte, Brazil (n=1,372) and of these a subgroup of subjects were followed longitudinally. Subsequent incident cases of VL were ascertained from a public health database through 2018. A subgroup (n=69) of the cross-sectional study subjects was chosen to assess immune status (T cell activation, senescence, exhaustion) and outcome. The data were compared between asymptomatic HIV+/L. infantum+ (HIV/Leish), symptomatic visceral leishmaniasis (VL), recovered VL, DTH+ (Delayed-Type Hypersensitivity response – Leishmanin skin test), AIDS/VL, HIV+ only (HIV+), and Non-HIV/Non L. infantum infection (control subjects). RESULTS: The cross-sectional study showed 24.2% of HIV+ subjects had positive anti-IgG Leishmania antibodies. After 3 years, 2.4% (8 of 333) of these HIV/Leish coinfected subjects developed AIDS/VL, whereas 1.05% (11 of 1,039) of HIV subjects with negative leishmania serology developed AIDS/VL. Poor adherence to antiretroviral therapy (p=0.0008) or prior opportunistic infections (p=0.0007) was associated with development of AIDS/VL. CD4+ (p=0.29) and CD8+ (p=0.38) T cells counts or viral load (p=0.34) were similar between asymptomatic HIV/Leish and HIV subjects. However, activated CD8(+)CD38(+)HLA-DR(+) T cells were higher in asymptomatic HIV/Leish than HIV group. Likewise, senescent (CD57+) or exhausted (PD1(+)) CD8(+) T cells were higher in asymptomatic HIV/Leish than in AIDS/VL or HIV groups. CONCLUSION: Although asymptomatic HIV/Leish subjects had normal and similar CD4+ and CD8+ T cells counts, their CD8(+)T cells had increased activation, senescence, and exhaustion, which could contribute to risk of developing VL.